Possis asked for more information on AngioJet:
This article was originally published in Clinica
Executive Summary
The US FDA has asked Possis Medical for more data to support its AngioJet 510(k) application. Possis submitted the thrombectomy device for peripheral applications in March (see Clinica No 696, p 22). It says it will be able to respond in about six weeks.